Announced Fri, 16 May · 17:33 IST

Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meeting on May 21, 2025.

Board & Shareholder Meetings View source PDF

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Senores Pharmaceuticals has informed the stock exchanges about an upcoming analyst and institutional investor meeting scheduled for May 21, 2025, between 11:00 AM and 4:00 PM in Mumbai. The meeting is being held as part of Centrum Broking's Nakshatra Investor Conference and will include both group sessions and one-on-one meetings in physical mode. The company has clarified that discussions will be limited to publicly available information, and no unpublished price-sensitive information (UPSI) will be shared. The investor presentation is already available on the company's website for reference.

Likely market impact

This is a routine regulatory disclosure under SEBI Listing Regulations indicating active investor engagement by the company. It is unlikely to have any direct impact on the stock price since no new material information is being shared, though it reflects ongoing institutional outreach efforts.